Current status and future perspectives of antibody-drug conjugates in breast cancer therapy
Antibody-drug conjugates (ADCs) represent a breakthrough in precision therapy for breast cancer, offering a unique targeted drug delivery mechanism that enhances tumor selectivity while reducing the nonspecific toxicity associated with conventional chemotherapy. In recent years, the clinical applica...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2025-02-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1742381051110-691893718.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|